1 / 14

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

Renub Research (http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php)has announced the addition of the "Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global" report to its offering<br>

renubresearch
Download Presentation

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global Renub Research www.renub.com Published: August, 2015 Copyright © 2015 Renub Research – All Rights Reserved

  2. Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have captured maximum market share of the Hepatitis C market.

  3. Continue (www.renub.com) Gilead currently dominates the multi-billion dollar Hepatitis C market, but AbbVie has been trying to increase its market share since U.S. regulators approved the marketing of its Viekira Pak. Drug makers are already focusing on introducing new drugs in the market as several drugs are standing in the pipeline. Hepatitis C Drugs is anticipated to be a rosy market for future period.

  4. Continue (www.renub.com) This is3rd edition report on Hepatitis C Drugs Industry. Report titled “Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global”provides a comprehensive assessment of the fast-evolving, high-growth of Hepatitis sector. This 87 page report with 18 Figures and 1 Table studies the Hepatitis C Drug Market Landscape.

  5. Continue (www.renub.com) • Hepatitis C Drugs Market & Forecast (Chapter 2) • Hepatitis C Approved Drugs Sales & Forecast (Chapter 3) • Hepatitis C – Pipeline Drugs Sales & Forecast (Chapter 4) • Hepatitis C Deals & Acquisitions (Chapter 5) • Hepatitis C – Company Wise Clinical Trial Analysis (Chapter 6)

  6. Continue (www.renub.com) • Hepatitis C – Approved Drugs Sales & Forecast (To 2020) (Chapter No. 3) • Pegasys • Pegintron • Incivek • Victrelis • Olysio • Sovaldi/Harvoni • HCV Franchise • ViekiraPak

  7. Continue (www.renub.com) • Hepatitis C – Pipeline Drugs Sales Forecast (To 2020) (Chapter No. 4) • Drug A (Merck & Co. Inc.) • Drug B (Merck & Co. Inc.) • Drug C (Bristol-Myers Squibb)

  8. Continue (www.renub.com) Hepatitis C – Company Wise Clinical Trial Analysis (Chapter No.5)1.  AbbVie2.  Bristol-Myers Squibb (BMS)3.  Gilead Sciences4.  Merck & Co. Inc.5.Tibotec/Janssen Therapeutics

  9. Order Form • Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 • Questions? Please call • +1-678-302-0700 (USA) • +91-120-421-9822 (India), ,+91-120-424-9780 • or mail to info@renub.com

  10. Format Report Title: Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global For More Details: http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php

  11. For ordering this report: Easy ways to place your order Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php

  12. Bank Details Account Name:Renub Research A/C No.:109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code:IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India

  13. Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:

  14. Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

More Related